pocketful logo
Panacea Biotec Ltd logo

Panacea Biotec Ltd

NSE: PANACEABIO BSE: 531349

₹331

(-1.53%)

Wed, 11 Mar 2026, 02:27 am

Panacea Biotec Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters72.4872.4872.4872.4872.49
FII1.361.060.781.160.38
DII1.851.811.521.491.17
Public24.3024.6625.2224.8625.97
Government00000

Panacea Biotec Ltd Shareholding Pattern

The Panacea Biotec Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Panacea Biotec Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Panacea Biotec Ltd (NSE: PANACEABIO, BSE: 531349) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Panacea Biotec Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Panacea Biotec Ltd Shareholding Pattern (Latest)

The latest Panacea Biotec Ltd shareholding for Dec 2025 is:

  • Promoters: 72.48%
  • FII: 1.36%
  • DII: 1.85%
  • Public: 24.30%
  • Government: 0%

Promoter holding in Panacea Biotec Ltd remains stable, reflecting consistent long-term commitment.

Panacea Biotec Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Panacea Biotec Ltd.

  • Dec 2025: 72.48%
  • Sept 2025: 72.48%
  • Jun 2025: 72.48%
  • Mar 2025: 72.48%
  • Dec 2024: 72.49%

Promoter stake remains largely stable, showing consistent ownership structure.

Panacea Biotec Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Panacea Biotec Ltd.

  • Dec 2025: 1.36%
  • Sept 2025: 1.06%
  • Jun 2025: 0.78%
  • Mar 2025: 1.16%
  • Dec 2024: 0.38%

FII holding in Panacea Biotec Ltd has increased recently, indicating rising foreign investor interest.

Panacea Biotec Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

  • Dec 2025: 1.85%
  • Sept 2025: 1.81%
  • Jun 2025: 1.52%
  • Mar 2025: 1.49%
  • Dec 2024: 1.17%

DII stake in Panacea Biotec Ltd has increased over time, indicating growing domestic institutional confidence.

Panacea Biotec Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

  • Dec 2025: 24.30%
  • Sept 2025: 24.66%
  • Jun 2025: 25.22%
  • Mar 2025: 24.86%
  • Dec 2024: 25.97%

Public holding remains stable with consistent retail participation.

Panacea Biotec Ltd Government Holding

Government holding in Panacea Biotec Ltd currently stands at 0%.

Panacea Biotec Ltd operates without significant government ownership.

Panacea Biotec Ltd Shareholding Analysis Summary

The Panacea Biotec Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Panacea Biotec Ltd shows strong promoter and domestic institutional confidence, which is positive for long-term investors.

Regular monitoring of the Panacea Biotec Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800